[1]           Rice DPJAJoPH, Health tN. Estimating the cost of illness. 1967;57(3):424-40.

[2]           Shankar S, Boyanagari M, Boyanagari VK, Shankar M, Ayyanar RSJCE, Health G. Profile of breast cancer patients receiving government sponsored free treatment and the associated economic costs. 2018;6(4):203-7.

[3]           McKibbin W, Fernando RJAEP. The global macroeconomic impacts of COVID-19: Seven scenarios. 2021;20(2):1-30.

[4]           Fernandes NJAaS. Economic effects of coronavirus outbreak (COVID-19) on the world economy. 2020.

[5]           Makridis C, Hartley JJSEPB. The cost of covid-19: A rough estimate of the 2020 us gdp impact. 2020.

[6]           Organization WH. Coronavirus disease 2019 (‎ COVID-19)‎: situation report, 94. 2020.

[7]           Nguyen HC, Nguyen MH, Do BN, Tran CQ, Nguyen TT, Pham KM, et al. People with suspected COVID-19 symptoms were more likely depressed and had lower health-related quality of life: the potential benefit of health literacy. 2020;9(4):965.

[8]           Moradzadeh RJE, Infection. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020. 2020;148.

[9]           Nayeri ND, Taghavi T, Shali MJBJ. Ethical challenges in the care of emerging diseases: A systematic literature review. 2017;7:85-96.

[10]        Arabi YM, Murthy S, Webb SJIcm. COVID-19: a novel coronavirus and a novel challenge for critical care. 2020;46(5):833-6.

[11]        Huo X, Chen L-L, Hong L, Xiang L-H, Tang F-Y, Chen S-H, et al. Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013–2014. 2016;5(1):1-8.

[12]        Rootman I, Goodstadt M. Evaluation in health promotion: principles and perspectives: WHO Regional Office Europe; 2001.

[13]        Bartsch SM, Ferguson MC, McKinnell JA, O'shea KJ, Wedlock PT, Siegmund SS, et al. The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States: A simulation estimate of the direct medical costs and health care resource use associated with COVID-19 infections in the United States. 2020;39(6):927-35.

[14]        Lee GM, Lett S, Schauer S, LeBaron C, Murphy TV, Rusinak D, et al. Societal costs and morbidity of pertussis in adolescents and adults. 2004;39(11):1572-80.

[15]        Xiao F, Chen B, Wu Y, Wang Y, Han DJZlxbxzzZlz. Analysis on the cost and its related factors of clinically confirmeds severe acute respiratory syndrome cases in Beijing. 2004;25(4):312-6.

[16]        Zhou L, Situ S, Huang T, Hu S, Wang X, Zhu X, et al. Direct medical cost of influenza-related hospitalizations among severe acute respiratory infections cases in three provinces in China. 2013;8(5):e63788.